Table 1 KEGG pathway enrichment analysis.
Pathway | Pathway ID | All genes with pathway annotation (16857) | P-value | Differentially expressed genes |
---|---|---|---|---|
Cell adhesion molecules | ko04514 | 223 (1.32%) | 0.0101 | 22329, 54725, 66871, 20970 |
Chemokine signaling | ko04062 | 281 (1.67%) | 0.0091 | 12772, 12767, 66871 |
Primary immunodeficiency | ko05340 | 50 (0.3%) | 9.42213e-05 | 16136, 12526, 12501 |
Staphylococcus aureus infection | ko05150 | 112 (0.66%) | 2.150739e-07 | 12262, 246256, 14289, 12259, 14131 |
Systemic lupus erythematosus | ko05322 | 184 (1.09%) | 6.912139e-05 | 12262, 16819, 246256, 12259, 14131, 12260 |
Natural killer cell mediated cytotoxicity | ko04650 | 256 (1.52%) | 0.0001 | 15216, 14131, 246256, 22177, 14127, 224840 |
Fc gamma R-mediated phagocytosis | ko04666 | 187 (1.11%) | 0.0342 | 246256, 14131, 66871 |
Phagosome | ko04145 | 344 (2.04%) | 0.0501 | 246256, 14131, 17533 |
B cell receptor signaling | ko04662 | 147 (0.87%) | 0.0064 | 213002, 66141 |
Transcriptional misregulation in cancer | ko05202 | 372 (2.21%) | 0.0503 | 98752, 18507, 17394 |
Amino sugar and nucleotide sugar metabolism | ko00520 | 82 (0.49%) | 0.0161 | 12655, 12654 |